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ABSTRACT 
Periodontitis is a microbial-induced, chronic inflammatory disease that affects tissue and 
bone anchoring the teeth, and can ultimately lead to tooth loss. In addition, periodontitis may 
contribute to systemic diseases, such as cardiovascular disease (CVD), diabetes, rheumatoid 
arthritis (RA), and inflammatory bowel diseases. The pathogenesis of periodontitis is 
complex and involves bacterial products and host-immune response, as well as genetic and 
environmental factors. Despite extensive studies, the specific genes and mechanisms 
contributing to disease initiation and progression are poorly understood. The main aim of this 
thesis was to add to current knowledge of the disease; for this, we generated the 
transcriptomic and taxonomic profiles from gingival tissue and saliva samples collected from 
patients with periodontitis and from healthy controls.  
Study I explored the gene expression profile of periodontitis compared to the healthy state. 
Using RNA sequencing (RNA-seq) we characterized the gene expression of gingival biopsies 
from 62 patients with periodontitis and 62 healthy controls. In patients with periodontitis, 
RNA-seq showed that genes related to inflammation, the wounding and defence responses, 
apoptosis, and cell death were up-regulated compared with the controls while genes related to 
extracellular matrix organization and structural support were down-regulated. The two most 
highly up-regulated genes in periodontitis were mucin 4 (MUC4) and matrix 
metalloproteinase 7 (MMP7). Comparisons of the gene expression profiles of periodontitis, 
CVD, RA, and the inflammatory bowel disease ulcerative colitis (UC) identified only one 
gene that was commonly up-regulated in all four inflammatory conditions: pleckstrin 
(PLEK).  
Study II investigated the protein products of MUC4 and MMP7 in saliva and gingival 
crevicular fluid (GCF) samples from patients with periodontitis and from healthy controls. 
MUC4 levels were significantly lower in the saliva and GCF samples of patients with 
periodontitis compared to the controls, whereas MMP7 levels were significantly higher. 
Controlling for age and smoking, analyses revealed a significant association between MUC4 
levels and periodontitis. Analysis that controlled for total protein levels, age, and smoking 
also found a significant association between the ratio of MUC4 to MMP7 levels and 
periodontitis, suggesting that this combination of MUC4 and MMP7 could possibly be used 
as a diagnostic marker for periodontitis.  
Study III used 16S ribosomal RNA gene sequencing to characterize the taxonomic 
composition in saliva and investigate the correlation between presence of microorganisms 
and levels of host inflammatory mediators in samples from 46 patients with periodontitis and 
47 healthy controls. The composition of the microbial community differed significantly 
between these two groups. The microbes Prevotella sp., Phocaeicola sp., Fretibacterium sp., 
Streptococcus mitis/parasanguinis, Eubacterium saphenum, Tannerella forsythia, Filifactor 
alocis, and Parvimonas micra were elevated in the patients with periodontitis, as was the 
inflammatory mediator glycoprotein 130 (gp130). This mediator, as well as soluble tumour 
necrosis factor receptor 1 (sTNF-R1), sTNF-R2, soluble interleukin-6 receptor α (sIL-6Rα), 
  
pentraxin 3, and chitinase-3-like 1, were identified as positively correlated with the microbes 
Streptococcus sp., Selenomonas sp., Treponema sp., and Selenomonas sputigena. In contrast, 
we found the anti-inflammatory mediator IL-10 to be negatively correlated with 
Streptococcus sp., Eubacterium nodatum, and Filifactor alocis, and positively correlated with 
Granulicatella elegans.  
The final two studies of this thesis investigated the patterns of local gene expression in tissue 
sections. Study IV developed a technique for RNA-seq analysis within tissue sections, which 
Study V then used in periodontitis-affected gingival tissue. Differential expression analysis 
between inflamed compared with non-inflamed areas in the gingival tissue revealed 442 
up-regulated genes in the inflamed domain. The three most highly up-regulated genes in the 
inflamed domain were immunoglobulin lambda like polypeptide 5 (IGLL5), signal sequence 
receptor subunit 4 (SSR4), and marginal zone B and B1 cell specific protein (MZB1). In 
contrast, we identified no down-regulated genes in the inflamed area when compared to the 
non-inflamed area. 
In summary, the studies in this thesis have used massively parallel sequencing to generate 
transcriptomic and taxonomic characterizations of gingival tissue and saliva samples from 
patients with periodontitis and healthy individuals in an attempt to identify specific genes 
involved in the pathogenesis of periodontitis. The thesis also identifies candidate biomarker 
proteins and microbes for future diagnostic assessment of the chronic inflammatory disease 
periodontitis.  
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INTRODUCTION 
  
  2 
n most people, the oral microbiome will at some point in their lifetime cause 
inflammation. This inflammation is usually short-lived, with the affected tissue 
recovering to a normal state. In some individuals, however, the inflammation does not 
resolve and instead becomes chronic. The chronic inflammation of periodontitis, the disease 
that is the focus of this thesis, perpetuates tissue destruction when left unchecked, ultimately 
resulting in tooth loss; thus the same host system that protects us is also responsible for the 
destruction of periodontal tissue. The disease course of periodontitis is “silent”, and patients 
rarely experience any symptoms before the disease has reached an advanced stage. Severe 
periodontitis has been linked to heightened systemic inflammation in the body and associated 
with other chronic inflammatory diseases. Early diagnosis greatly improves clinical outcome, 
but no biomarkers for early clinical detection of periodontitis have been confirmed. The 
introductory section of this thesis presents a brief background of the pathogenesis of 
periodontitis, the association between periodontitis and systemic diseases, the current state of 
research on biomarkers for periodontitis, and a review of recent studies on the transcriptome 
of periodontitis and the microbiota involved in this disease.   
I 
  3 
PERIODONTITIS 
Periodontitis is a complex microbial-induced chronic inflammatory disease of the gingiva that 
destroys tooth-supporting structures, and can ultimately lead to tooth loss (Figure 1). 
Periodontitis is the most prevalent chronic inflammatory disease in humans today and has 
probably been common for ~10,000 years (after the domestication of animals and plants that 
led to a compositional shift in oral microbiota).1,2 In 2010, almost half of the adult population 
was affected by periodontitis in some form and its severe form is estimated to affect 743 
million people worldwide (nearly 11% of the world population).3 Periodontitis is not a deadly 
disease, however, numerous studies have reported indications that it is associated with 
systemic diseases.4 Moreover, periodontitis negatively affects the quality of life. Tooth 
loosening makes chewing more difficult and can therefore have a negative impact on 
nutrition and diet; aesthetic concerns may adversely affect the patient’s social life.5-8 
 
The pathogenesis of periodontitis involves interactions between bacterial products and the 
host-immune response, which are greatly influenced by genetic and environmental factors 
(Figure 2).9 Gingivitis, a common inflammation caused by accumulation of bacteria in the 
form of dental plaque on the tooth close to the gingiva, always precedes periodontitis. Signs 
of gingivitis include gingival swelling, redness and bleeding.10 In healthy individuals, tooth 
brushing and flossing, which remove the dental plaque, will reverse this condition.11 Gingival 
inflammation in individuals who are susceptible for periodontitis however, does not resolve 
and instead progresses into a chronic inflammation.12 In this scenario, inflammatory cells and 
resident cells persistently overexpress inflammatory mediators and proteolytic enzymes, 
causing the tissue and alveolar bone that support the teeth to degrade.13 
Clinical outcomes likely depend on a combination of genetic and environmental factors. 
Genetic factors responsible for regulating inflammation either providing protection or 
increasing susceptibility, influence the host-immune response. Comorbidities, especially 
diabetes mellitus and atherosclerosis, may exacerbate the inflammatory state.5 And 
environmental factors, including excessive plaque accumulation and smoking, have been 
reported to influence the disease course.14-16  
Figure 1. Schematic illustration of healthy periodontal 
tissue (left) and periodontitis (right). Periodontitis is 
characterized by degradation of connective tissue and 
alveolar bone.  
Adapted from Yucel-Lindberg and Båge 201312, reprinted 
with permission from Cambridge University Press.  
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Diagnoses of periodontitis are mostly based on clinical evaluation of the soft tissue and bone 
loss around the teeth, including measurement of probing pocket depth (PPD), clinical 
attachment loss (CAL), and bleeding on probing (BOP).5,17 Periodontal treatment initially 
involves improved dental care and removal of dental plaque by scaling and root planning, 
whereas more severe periodontitis can be subject to surgery.5 Because the loss of soft tissue 
and alveolar bone is largely irreversible, timely and accurate diagnosis is crucial. However, 
periodontitis is a “silent” disease and in the early stages the patient rarely experiences any 
symptoms.5  
Early diagnosis of periodontitis greatly improves clinical outcomes.5 CAL measurements 
provide information on past tissue destruction; however PPD, CAL, and BOP do not predict 
future disease states.18 Thus, considerable effort has been invested in exploring the use of 
inflammatory mediators and enzymes as early detection markers for periodontitis. To date, 
however, no marker has yet been identified as more sensitive than clinical measurements of 
BOP, PPD, and CAL.5  
To summarize, periodontitis is a chronic inflammatory disease of the periodontium initiated 
by microbiota and maintained by the host inflammatory response. Infiltration of the 
supporting soft tissue and bone by inflammatory cells with the subsequent production of 
inflammatory mediators causes the destruction of bone and tissue that are vital for tooth 
support. Upcoming sections will cover these processes in more detail. 
Microbial
challenge
Host
immuno-
inflammatory
response
Connective
tissue
and bone
metabolism
Clinical signs 
of disease 
initiation and 
progression
Environmental and acquired risk factors
Genetic risk factors
antibody
PMNs
antigens
LPS
cytokines
prostanoids
MMPs
Figure 2. Pathogenesis of periodontitis. Periodontitis results from a complex interaction between the 
microbial challenge, host immune-inflammatory response and environmental and genetic risk factors. The 
outcome is destruction of connective tissue and alveolar bone.  
LPS, lipopolysaccharide; MMPs, matrix metalloproteinases; PMNs, polymorphonuclear leukocytes.  
Adapted from Page and Kornman 19976, reprinted with permission from John Wiley and Sons.  
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Microbial challenge 
More than 700 bacterial species have been identified in the oral cavity.19 These 
microorganisms can be found both on soft tissue and on teeth were they form biofilms, 
meaning “a community of microorganisms attached to a surface”.20,21 The most prevalent oral 
biofilm, dental plaque, exist on tooth surfaces in the form of complex multispecies 
communities.21 
The biofilm formation starts with adherence of “early colonizers” that are species with the 
ability to attach to host-derived glycoproteins, mucins, and other proteins naturally coating 
the tooth surface.21,22 The biofilm continues to develop as the late colonizers aggregate to the 
early colonizing bacteria.20,21 As the biofilm matures and develop subgingivally, there is also 
a gradual shift from Gram-positive aerobic bacteria toward Gram-negative and anaerobic 
species.16,21,23 Increasing gingival pocket depth changes the gingival environment with 
respect to pH and oxygen levels, which promotes species favoured by this milieu.21,24 In 
addition, the inflammatory response from the host can enrich the environment with 
inflammatory breakdown products that enhance the growth of certain “inflammophilic” 
bacteria, which feed off inflammatory products.25  
Throughout history there have been attempts to identify specific species responsible for 
periodontitis. In the 1800s, microorganisms were considered as a direct causing agent for 
periodontal tissue destrucion.16,26 However, the failure to identify specific pathogens led to 
the “nonspecific plaque” hypothesis with the assumption that the quantity of dental plaque 
was the cause of periodontitis, which was the focus of studies between the 1930s and the 
1970s.21,27 This theory was challenged by the identification of certain species associated with 
diseased sites. A landmark study in 1998 by Socransky et al. utilizing a DNA hybridization 
method identified several bacterial complexes associated with either health or disease. Five 
major groups of bacteria associated with health or disease were identified and given specific 
colour designations. Most notably among these complexes was the “red” complex comprising 
the three species Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola, 
identified as strongly associated with periodontitis.28 This paradigm has prevailed until 
recently, partly because of the biasness from the use of culture based methods, which may 
have overestimated the importance of easily grown species.25 
Dental plaque associated both with clinically healthy and diseased sites have now been 
extensively studied. These studies have revealed that the microbiota in dental plaque is much 
more diverse than previously considered.29 The current consensus is that a dysbiotic 
community of microbiota is responsible for the initiation and maintenance of periodontitis. It 
seems obvious that no single pathogen is causative on its own and that multiple species 
synergistically form dysbiotic communities contributing to periodontitis. However, it is still 
not elucidated which specific microorganisms drive the onset and/or development of 
periodontitis.16,26,30 
  6 
Host response 
Although bacteria are considered as the main etiological agent for periodontitis, their 
presence is not directly responsible for the tissue destruction. It is rather the exaggerated host 
inflammatory response that causes degradation of periodontal tissues.31  
Periodontal disease is initiated by a biofilm formation in connection to the gingiva and the 
subsequent release of bacterial products such as lipopolysaccharide (LPS), peptidoglycans, 
proteases, and toxins. These substances are recognized by host inflammatory and resident 
cells equipped with receptors called pattern recognition receptors (PRRs), and an 
inflammatory response is triggered12,32,33. The host inflammatory response is mediated mainly 
by neutrophils, monocytes/macrophages, and T- and B-lymphocytes, as well as by resident 
cells in the tissue. These cells release inflammatory mediators, including cytokines, 
chemokines and proteolytic enzymes, which collectively contribute to destruction of tissue 
and alveolar bone.12,13,34-37 
Epithelial cells are the first cells that come into contact with microbial substances. The 
epithelium functions as a physical barrier against microorganisms and elicits innate and 
acquired immune responses. Upon stimulation, oral epithelial cells express different pro-
inflammatory cytokines and chemokines, including interleukin (IL)-1α, IL-1β, IL-6, IL-8, 
and tumour necrosis factor  α (TNF-α), which act as pro-inflammatory signalling 
molecules.38-44 Through a series of events, mast cells within the epithelium are stimulated to 
release vasoactive amines and TNF-α, which contribute to vascular permeability, as well as 
increased expression of adhesion molecules on endothelial cell surfaces, which allows 
inflammatory cells that circulate in the blood stream to enter the tissue.12,32,45 Moreover, 
dendritic cells take up microbial antigenic products, migrate to the lymph nodes where they 
encounter T-cells to which they present the antigens.5,46 
The first inflammatory cells to arrive to the infected tissue are polymorphonuclear leukocytes 
(PMNs). At the site of infection, PMNs release proteases, such as matrix metalloproteinases 
(MMPs) and other proteolytic enzymes in order to eliminate microorganisms, but these 
enzymes also contribute to tissue degradation.25,47,48 In addition to the production of enzymes, 
activation of PMN cells also results in synthesis of pro-inflammatory cytokines such as IL-1β 
and TNF-α, which further enhance the inflammatory response.47 Moreover, resident cells in 
the tissue, which are predominantly fibroblasts, respond to the inflammatory milieu and 
release inflammatory mediators and degradation enzymes, contributing to disease 
persistence.49 Lymphocytes, mainly T-cells, and macrophages further invade the tissue and 
release pro-inflammatory mediators, including IL-1β and TNF-α, as well as proteolytic 
enzymes such as MMPs. At this stage, the gingival tissue damage is reversible and it is 
possible for the damaged tissue to heal and remodel. However, in individuals susceptible for 
developing periodontitis, the inflammation may change character into a B-cell/plasma cell 
response, with subsequent connective tissue degradation and irreversible bone loss.12,45,50,51 
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ASSOCIATIONS BETWEEN PERIODONTITIS AND SYSTEMIC DISEASES 
Periodontitis has been linked to increased systemic inflammation in the body, indicated by 
raised levels of cytokines and acute-phase markers, such as IL-6 and C-reactive protein, 
respectively.16 Although causal links between periodontitis and systemic diseases have not 
been identified, associations have been reported between periodontitis and diseases such as 
diabetes mellitus, cardiovascular disease (CVD), rheumatoid arthritis (RA), and inflammatory 
bowel disease (IBD).  
Diabetes mellitus is reported to be the most prevalent systemic disease that increases the risk 
for periodontitis.5,52,53 The severity, prevalence, and progression of periodontitis are increased 
in individuals with diabetes.53-55 Hyperglycaemia, the hallmark of diabetes, can result in 
activation of pathways that increase inflammation, oxidative stress and apoptosis.56,57 
Conversely, research suggests also that chronic periodontitis negatively affects metabolic 
control in individuals with diabetes mellitus.56-58 Both periodontitis and diabetes mellitus are 
thought to adversely influence the patient’s metabolic balance and overall inflammatory 
burden.5  
Numerous cross-sectional, case-control, and epidemiological studies suggest that individuals 
with periodontitis have increased risk of CVD, independent of confounding factors, such as 
smoking.4,59-61 Moreover, clinical intervention studies imply that periodontal treatment 
reduces systemic inflammation and has positive effects on markers of atherosclerosis.4,60,62,63 
The mechanisms through which periodontitis is associated with CVD are not known. It has 
been proposed that bacteria translocate from the periodontal pocket into the gingival tissue, 
enter the circulatory system, and in that way provide an atherogenic stimulus. This is 
supported by the fact that DNA of periodontal bacteria has been found in human 
atheromas.4,64-69 In addition, pro-inflammatory cytokines produced in the periodontium could 
translocate into the bloodstream, induce an acute-phase response in the liver and thereby 
promote atherogenesis.4,70,71 This assumption is supported by the fact that individuals with 
severe periodontitis have elevated levels of cytokines and acute-phase markers in serum 
compared to healthy controls without periodontitis. Treatment of periodontitis has also been 
demonstrated to decrease levels of these systemic inflammatory mediators.4,60,62  
The association between RA and periodontitis has been assumed based on the similar 
characteristics of the diseases, which are common chronic inflammatory events and local 
pathological outcomes.72 There are conflicting reports on the association between 
periodontitis and RA, although increasing epidemiological data give support for a link, even 
after adjusting for common risk factors such as smoking.4,73-86 RA and periodontitis are 
hypothesized to be linked to each other through the periodontal pathogen P. gingivalis. DNA 
from P. gingivalis has been detected in synovial fluid of up to 80% of RA patients in contrast 
to healthy controls without RA.87-89 This periodontal bacterium has the unique capacity of 
inducing citrullination of proteins. Anti-citrullinated protein antibodies (ACPAs) have been 
detected in individuals up to fifteen years before clinical onset of RA, and it has been 
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reported that the levels of ACPAs are correlated with disease severity in individuals with 
RA.4,72,84,90  
Research on the association between periodontitis and IBD, including Crohn’s disease and 
ulcerative colitis (UC) indicate that there might be a link between these diseases.91-97 Similar 
immunopathogenesis between IBD and periodontal disease has been proposed due to the 
characteristics of the diseases.98 Both periodontitis and IBD are multifactorial diseases 
initiated by bacteria, in which immune system, genetics and environmental factors are 
involved.99 Notably, IBD often have oral manifestations, with prevalence between 20-50%, 
and these oral manifestations can in some cases be present years before onset of IBD.100-103  
 
CANDIDATE BIOMARKERS FOR PERIODONTITIS 
Clinical measures such as PPD, CAL, and BOP are today the basis for diagnosis of 
periodontitis. However, the measurement of these parameters requires a trained dental 
professional, and when these clinical signs appear, the disease has largely progressed to an 
irreversible stage. Therefore, substantial efforts are being put into identifying biomarkers for 
early detection of periodontitis.  
Potential biomarkers have been investigated in saliva and gingival crevicular fluid (GCF), the 
exudate that fills the gingival pockets. Saliva is more suitable as a diagnostic fluid than is 
GCF because it is more easily and non-invasively obtained. Furthermore, GCF reflects 
inflammatory processes at specific and localized sites, while saliva reflects the inflammatory 
status of all sites, which is likely to be more clinically relevant.104 
Proteins that have been investigated as potential biomarkers include markers of inflammation 
(IL-1β105-108, IL-6109-114, macrophage inflammatory protein 1α [MIP-1α]115,116, prostaglandin 
E2 [PGE2]117, and TNF-α118-120), markers of connective tissue degradation (MMP8118,120-123, 
MMP9116,121,123,124, tissue inhibitor of metalloproteinases 1 [TIMP-1]107,120,124, aspartate 
aminotransferase [AST]122,125-130, and alkaline phosphatase [ASP]119,126,127,130), as well as 
markers of alveolar bone turnover/resorption (osteoprotegerin [OPG]116,119,121,123,131 and 
carboxyterminal telopeptide of type I collagen [CTX]116,120,121,123,132). Moreover, microbial 
pathogens have been suggested as potential biomarkers for periodontitis (Aggregatibacter 
actinomyctemcomitans115,120, P. gingivalis107,121,123,126,133, Prevotella intermedia126,133, 
T. forsythia107,121,123,133, and T. denticola121,123,133).134  
Recently, a meta-review focusing on the sensitivity and specificity of reported host-derived 
potential biomarkers was published.135 In this review the authors identified one salivary 
biomarker, MIP-1α, that could discriminate between periodontitis and health with high 
accuracy.116 In addition, the meta-analysis identified two biomarkers, IL-1β and IL-6, to have 
acceptable accuracy for the assessment of periodontitis.117,136 However, the authors of the 
meta-review concluded that these findings need to be validated by additional larger studies.135  
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When IL-1β and IL-6 were analysed in combination with each other or together with MMP8, 
they had better accuracy in discriminating periodontitis and health than when analysed 
alone.136 These findings suggest that a panel of biomarkers may have better diagnostic utility 
than single markers. Moreover, some studies have reported promising results on the 
combination of host-derived and bacterial markers as diagnostic tools for 
periodontitis.121,123,137,138 For instance, Salminen et al. (2014) reported on the salivary levels 
of MMP8, IL-1β, and P. gingivalis. The levels of these three markers were combined into 
“cumulative risk scores”, which demonstrated strong association with periodontitis.138 MMP8 
is also today the only biomarker commercially available, in some European countries.5,139  
 
TRANSCRIPTOME ANALYSIS OF PERIODONTITIS  
Techniques for gene expression analysis 
Genome-wide transcriptome analysis is now routine thanks to technical advances during the 
last decades. High throughput analysis of whole transcriptomes first became possible with 
microarrays, which are still being used in many laboratories, although now being largely 
replaced by massively parallel sequencing. Genome-wide transcriptome studies, as performed 
by microarrays or massively parallel sequencing, are usually carried out for exploratory 
analysis as a guidance for subsequent analysis. For studies where the genes of interest are 
already identified, targeted approaches for gene expression, such as reverse transcription 
quantitative polymerase chain reaction (RT-qPCR), or in situ hybridization (ISH), are 
commonly performed.  
Microarray technology was the first high-throughput method for gene expression analysis. 
Microarrays consist of clusters of DNA probes immobilized in discrete locations on solid 
substrates, for instance glass slides. Fluorescently labelled complementary DNA (cDNA) 
derived from transcripts can hybridize to the array and the intensities of the fluorescent 
signals are used to determine the amount of bound cDNA.140 While microarrays allow for 
analysis of whole transcriptomes, the sequences need to be known beforehand for design of 
the probes on the microarray.141 
Massively parallel sequencing approaches (also called next generation sequencing) were 
introduced in the early 2000s and their use has steadily grown since then, due to increase in 
throughput and decrease in costs.142 Today, Illumina is undoubtedly the largest sequencing 
platform on the market. The technology uses a sequencing-by-synthesis approach where 
fluorescently labeled nucleotides are added sequentially to clusters of single stranded DNA 
molecules. The sequence of bases is deciphered by recording the fluorescent signals.143 
Compared to microarrays, massively parallel sequencing has a greater dynamic range, higher 
sensitivity and specificity, and it has the ability to detect novel transcripts.141,144-147 
Most studies on tissue transcriptomes have been performed on RNA extracted from whole 
biopsies, thus producing data that represent averages of the gene expression across all cells 
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within the biopsies. Therefore, several single-cell RNA sequencing (RNA-seq) technologies 
have been developed with optimization of library preparation protocols to handle less input 
material.148-151 Using these techniques new insights into development152,153, cancer154,155, 
neuroscience156,157, and inflammation158,159 have been gained.  However, while these methods 
can reveal cell-to-cell variability, they require tissue dissociation, which causes loss of 
positional information. For that reason, spatially resolved gene expression methods that add 
information on the localization of cells within tissue have been developed. For instance, laser 
capture microdissection has been used for dissecting cells or small anatomical regions from 
tissue sections followed by RNA-seq, using the single-cell RNA-seq methods describe 
above.160-162 Moreover, ISH techniques have been optimized to simultaneously target 
hundreds of different transcripts, down to single molecule resolution.163-167 Several additional 
techniques have been proposed, including sequencing directly in tissue sections and cells, 
although most of these methods are still at a proof-of-concept stage.168,169  
Capturing the transcriptome in its entirety, while at the same time preserving the exact spatial 
information of all transcripts, remains a distant goal for the above-mentioned techniques. 
However, considerable resources have been invested towards this goal and the resolution is 
increasing. In Study IV of this thesis, we propose a novel method for transcriptome-wide 
analysis of tissue sections with spatial resolution.  
Previous studies on periodontitis 
The global transcriptome profiles of periodontitis-affected gingival tissues in comparison to 
healthy gingival tissues have previously been investigated in a few studies. Most of these 
studies have been performed using microarrays, while two more recent studies employed 
RNA-seq for interrogating the transcriptome in periodontal tissues.  
In 2008, Papapanou and co-workers compared gene expression profiles of gingival biopsies 
from diseased and healthy sites in 90 patients with periodontitis. Their results demonstrated 
that differentially expressed genes were mainly related to apoptosis, antimicrobial humoral 
response, antigen presentation, regulation of metabolic processes, signal transduction, and 
angiogenesis.170 The same group also investigated the transcriptomes of gingival tissues in 
chronic and aggressive periodontitis, the two major forms of periodontitis. The differences in 
gene expression between the two groups were small. However, when they in another study 
applied a model-based clustering approach to the same data, they could identify two 
subgroups based on the transcriptome data instead of on the clinical parameters. The gene 
expression in the first subgroup was primarily related to cell proliferation while the second 
subgroup was associated with lymphocyte activation and unfolded protein responses.171,172 
The above-mentioned studies employed microarrays for the transcriptome analysis, and our 
group was the first to report the gene expression in periodontitis using RNA-seq technique. 
Twelve patients with periodontitis were included and two biopsies from each patient were 
collected – one from a periodontitis-affected site and one from a healthy site. The results 
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revealed that periodontitis-affected sites demonstrated an up-regulation of inflammatory 
pathways, compared to healthy sites.173 
In 2014, Becker and colleagues also used RNA-seq to investigate the transcriptome in 
periodontitis, peri-implantitis and healthy controls. In contrast to earlier studies, the healthy 
controls were periodontally healthy individuals. Their analysis identified up-regulation of 
genes related to bacterial response systems in patients with periodontitis compared to healthy 
controls. However, the study group was small, including only seven patients with 
periodontitis and seven healthy controls and the results should therefore be interpreted with 
caution.174  
The studies described above have reported genes that are up- and down-regulated in 
periodontitis, as well as their related functions. However, to develop better understanding of 
this chronic condition, follow-up studies should be performed to elucidate the mechanisms by 
which these genes contribute to periodontitis. Besides that, gene expression data obtained 
from these studies originated from biopsies with heterogeneous cell populations, including 
epithelial cells, fibroblasts, and infiltrating inflammatory cells. Novel methods that can 
associate gene expression with different cell types, as discussed in the previous section, are 
important to increase the knowledge of the complex disease periodontitis.  
 
TAXONOMIC CHARACTERIZATION OF PERIODONTITIS – PREVIOUS STUDIES 
Historically, identification of bacterial taxa has relied on culture-based methods. Later on, 
when microarrays became started to be used for genomic analyses, they were applied also for 
investigations of the oral microbiome. With subsequent advancements of sequencing 
technologies, the understanding of the oral microbiome has been largely expanded and well 
studied. This section will mainly cover recently reported studies, with focus on studies using 
high-throughput sequencing and including a relatively high number of samples.  
A study that is worth mentioning is one by Socransky et al in 1998, although this study was 
not recent and did not use high-throughput sequencing.28 In this study, microbiota identified 
in plaque samples were grouped into five complexes associated with health or disease.28 
Since then, more taxa have been identified, some of them having as good or better correlation 
with periodontitis than the red complex.25,175,176 However, the study by Socransky and 
colleagues was ground-breaking in the sense that it was the first study that put forward the 
idea that periodontitis is not initiated by a single species, but rather by a dysbiotic community 
of microbiota.177  
Regarding subgingival plaque samples, in 2012, Griffen and co-workers reported on bacterial 
communities from 29 patients with periodontitis and 29 healthy controls.176 In this study, the 
phyla Spirochaetes, Synergistetes, and Bacteroidetes were more abundant in samples from 
patients with periodontitis, whereas Proteobacteria was more abundant in health. Species 
reported as periodontitis-associated included Filifactor alocis, P. gingivalis and T. denticola, 
whereas Streptococcus mitis, Streptococcus sanguinis and Moraxella osloensis were health-
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associated.176 Besides that, Abusleme et al investigated the microbial communities in 
subgingival plaque samples from 22 patients with periodontitis and 10 healthy controls.175 
Plaque samples from patients with periodontitis demonstrated higher proportions of 
Spirochaetes, Synergistetes, Firmicutes and Chloroflexi, whereas Actinobacteria was more 
abundant in health.175  
In 2013, subgingival plaque samples from 88 patients with periodontitis were investigated by 
Ge et al.178 Two samples were collected from each subject; one sample from a deep pocket 
and the other one from a shallow pocket. Phyla Bacteroidetes and Spirochaetes were more 
abundant in deep pockets, whereas Firmicutes, Actinobacteria and Proteobacteria were 
reduced in number. At species level P. gingivalis, Porphyromonas endodontalis, 
Fusobacterium nucleatum, Prevotella nigrescens, T. denticola, Treponema medium, T. 
forsythia and Parvimonas micra were overrepresented in deep sites, whereas species 
overrepresented in shallow sites included Streptococcus oralis, S. sanguinis, Streptococcus 
gordonii, Rothia dentiocariosa, Veillonella dispar, Actinomyces naeslundii and Actinomyces 
sp.178 
In 2014, Li et al. interrogated 25 subgingival plaque samples from periodontitis patients and 
13 healthy control samples.179 At phylum level, Firmicutes, Bacteroidetes, Spirochaetes, 
Tenericutes, Chloroflexi, Synergistetes and Euryarchaeota were periodontitis-associated, 
whereas Proteobacteria was more abundant in health. Fusobacterium, Porphyromonas, 
Treponema, Filifactor, Eubacterium, Tannerella, Hallella, Parvimonas, Peptostreptococcus 
and Catonella were increased in periodontitis. The genera Neisseria, Corynebacterium, 
Capnocytophaga and Actinomyces were more abundant in samples from healthy controls. In 
this study, Filifactor was also emphasized as prevalent and strongly associated with 
periodontitis.179 
Next, Kirst et al. (2015) interrogated 25 plaque samples from patients with periodontitis and 
25 from healthy controls.180 The research group reported the species P. gingivalis, 
T. denticola, T. forsythia, F. nucleatum, F. alocis and Fretibacterium sp. as more abundant in 
periodontitis. Actinomyces sp., S. mitis, Streptococcus sanguis, Gemella haemolysans, and 
Granulicatella adjacens were associated with health.180  
Regarding saliva samples, fewer studies have been reported on the microbial composition in 
periodontitis. Among reported studies few have included a large cohort and used high-
throughput sequencing. One large study (139 patients with periodontitis and 447 healthy 
controls) was conducted by Belstrom et al, (2014) using microarray technique for taxonomic 
characterization of the salivary microbiota. Taxa that were reported as more abundant in 
periodontitis included T. forsythia, P. micra, and F. alocis.181 Moreover, a vast study was 
recently reported on samples from inhabitants of a town in Japan (2,343 participants), 
performed using 16S rRNA gene sequencing.182 In this study, the authors did not report on 
specific taxa associated with clinical periodontitis and health, but they reported that the 
phylogenetic diversity increased with clinical measures indicative of periodontitis, such as 
mean PPD, % teeth with BOP and plaque index.182  
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To summarize, the pathogenesis and etiology of periodontitis are gradually being elucidated, 
to a large extent spurred by technological advancements. Nonetheless, neither the precise 
mechanisms behind the pathogenesis of periodontitis, the interaction between microbiota and 
host-immune response, nor the link with systemic diseases are completely understood, and 
currently there are today no biomarkers with higher diagnostic precision than clinical 
examinations. Therefore, in this thesis, we have interrogated the transcriptome and 
microbiota associated with periodontitis by using massively parallel sequencing techniques in 
order to add to the knowledge of this complex disease, and to identify candidate biomarker 
proteins and microbes for future diagnostic assessment of periodontitis.  
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he overall aims of this thesis were to identify the genes involved in the pathogenesis 
of periodontitis, and to identify candidate biomarkers by investigating the 
transcriptomic and taxonomic profiles in gingival tissue or saliva samples from 
patients with periodontitis and healthy controls.  
 
STUDY I 
To characterize the global transcriptome of periodontitis, as well as its association to other 
chronic inflammatory disorders, by RNA-seq of gingival biopsies from patients with 
periodontitis in comparison to biopsies from healthy controls.  
 
STUDY II 
To investigate the levels of MUC4 and MMP7 in saliva and GCF samples from periodontitis 
patients and healthy controls. 
 
STUDY III 
To characterize the taxonomic composition of the salivary microbiota in periodontitis and the 
association between pathogens and the host’s immune and inflammatory mediators in saliva 
samples for periodontitis risk assessment. 
 
STUDY IV 
To develop a method that allows visualization and quantitative analysis of the transcriptome 
with spatial resolution in individual tissue sections.  
 
STUDY V 
To simultaneously quantify and localize gene expression in periodontitis-affected gingival 
tissue using the spatially resolved transcriptome analysis technique developed in Study IV.  
T 
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MATERIALS AND METHODS 
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his section gives a brief overview of all the methods used to obtain the results 
presented in this thesis. For more detailed protocols, including in-depth details such 
as concentrations or sources of reagents, the reader is referred to the materials and 
methods sections of the published studies and manuscripts provided in the appendix.  
 
  
T 
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ETHICAL CONSIDERATIONS 
All of the studies presented in this thesis were performed in accordance with the Declaration 
of Helsinki and current Swedish legislation. Ethical permit for collection of gingival tissue 
biopsies (Studies I and V) was approved by the Regional Ethics Board in Stockholm, 
Sweden. Collection of oral cells (Study I) was approved by the Regional Ethics Board in 
Stockholm. Collections of saliva and GCF samples (Studies II and III) were approved by the 
Regional Ethics Board in Stockholm or by the Ethical Review Board at the University of 
Lund, Sweden. Ethical permits for the collection of mouse olfactory bulbs and breast cancer 
biopsies, included in Study IV, were approved by the Stockholm North Animal Ethics 
Committee and the Ethical Review Board at the University of Lund, respectively. In all 
studies that involved human subjects, a written informed consent was obtained from each 
individual participant.  
 
SUBJECTS AND COLLECTION OF SAMPLES 
Gingival tissues  
A total of 144 gingival biopsies were collected for transcriptome analysis in Study I. The 
inclusion criteria for the patients with periodontitis were tooth sites with PPD ≥ 6 mm, 
CAL ≥ 5 mm, and BOP. The inclusion criteria for the healthy controls were PPD ≤ 3 mm, 
CAL ≤ 3.5 mm and no BOP. The biopsies were collected by calibrated dentists.  
The gingival tissues were split in halves, where one half was stored in RNA Later solution 
before being subjected to RNA-seq. The other half was fixed in buffered formalin before 
being sectioned and stained with hematoxylin and eosin (H&E) and/or analysed with 
immunohistochemistry. Biopsies stained with H&E were used for assessment of degree of 
inflammation, as evaluated by three “blinded” observers giving a score between 0 and 3 
(0 = no evidence of inflammatory infiltration, 1 = slight inflammatory infiltration, 
2 = moderate inflammatory infiltration, and 3 = severe inflammatory infiltration).  
For Study V, gingival tissues from patients with periodontitis were collected and immediately 
snap frozen in liquid nitrogen. The biopsies were cryosectioned onto glass slides, stained with 
H&E and visually inspected. The biopsy that showed the most intact histology was selected 
for analysis with spatial transcriptomics.   
Saliva samples 
Saliva samples, analysed in Studies II and III, were collected from two independent cohorts. 
In both studies, stimulated saliva samples were collected into test tubes while the subjects 
were chewing paraffin tablets. The samples were thereafter immediately frozen at -20 °C. 
The samples were thawed and centrifuged, and the supernatants were collected and aliquoted. 
The aliquots were stored at -80 °C until analysis.   
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In Study II, the inclusion criteria for patients with periodontitis were BOP in > 30% of sites 
and loss of supporting tissues exceeding 1/3 of the root length. 84 % of the patients had 
PPD ≥ 6 mm and 16 % had PPD 4-5 mm. The inclusion criteria for healthy controls were no 
signs of bone loss, BOP < 30 % and PPD < 4 mm. In total 37 individuals with periodontitis 
and 39 healthy controls were included in this study.  
In Study III, 48 patients with periodontitis and 48 healthy controls were included. The 
inclusion criteria for patients with periodontitis were tooth sites with BOP, PPD ≥ 6 mm and 
CAL ≥ 5 mm. Healthy control individuals had no signs of gingival inflammation and 
PPD ≤ 3 mm.  
GCF samples 
GCF samples from 20 patients with periodontitis and 20 healthy controls were included in 
Study II. These samples were collected by inserting paper strips into the gingival crevice and 
thereafter immersing the strips in phosphate buffered saline containing Tween. Samples were 
collected from sites with PPD ≥ 6 mm from patients with periodontitis, and from sites with 
PPD ≤ 3 mm from healthy controls.  
Cell cultures  
In Study I, the expression and regulation of MUC4, MMP7, and pleckstrin (PLEK) were 
investigated in vitro in oral cells. For MUC4 expression, studies were performed on human 
primary epithelial cells. As for MMP7 and PLEK, experiments were performed on fibroblast 
cells established from gingival tissue obtained from individuals with no clinical signs of 
periodontitis.  
 
TRANSCRIPTOMIC AND TAXONOMIC ANALYSES 
Transcriptomic and taxonomic analyses were performed in four of the studies (Studies I, III, 
IV, and V) included in this thesis, using massively parallel sequencing. In addition, RT-qPCR 
was also used in Study I for transcriptomic analysis. RT-qPCR is a low-throughput method 
suitable for analysis of a smaller number of transcripts. Therefore, in Study I, we used RT-
qPCR for validation of three up-regulated genes.  
The preparation of libraries (collections of DNA molecules ready for sequencing), for each 
study will be briefly covered in the sections below. In Study I, a library preparation protocol 
for RNA-seq was followed as provided by Illumina. In Study III, taxonomic profiling was 
performed by sequencing a region of the 16S rRNA gene in microbial DNA isolated from 
saliva samples. In Study IV, a novel RNA-seq method for transcriptome profiling with spatial 
resolution was developed, with an in-house developed library preparation protocol, which 
also was applied to a gingival biopsy in Study V.  
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RT-qPCR 
In Study I, RT-qPCR was employed to analyse the mRNA expression of MUC4, MMP7, and 
PLEK after stimulation with LPS in oral cells. The extracted RNA was first reverse 
transcribed into complementary cDNA and thereafter qPCR was performed using the cDNA 
as template.  
The TaqMan method was employed, which uses sequence specific reporter probes.183 The 
reporter probes, which contain both fluorophore and quencher anneals to the DNA template. 
When the polymerase synthesizes a new copy of the DNA during PCR, it degrades the 
reporter probes upon encountering, which separates the fluorophore and the quencher. This 
separation of the fluorophore and quencher creates a fluorescent signal that can be 
measured.183 In Study I, primers and reporter probes specific for MUC4, MMP7, PLEK, and, 
as reference, the housekeeping gene glyceraldehyde 3-phosphate-dehydrogenase (GAPDH) 
were used. 
Massively parallel sequencing 
In Studies I, III, IV, and V, massively parallel sequencing was mainly employed. In these 
studies we used the Illumina sequencing platform, which today is the largest sequencing 
technology on the market. In this section, library preparation and sequencing are described as 
below for Studies I and III, while alterations to these protocols, as incorporated in Studies IV 
and V, are covered in the next section.  
In Study I, RNA was first extracted from the 144 biopsies and the RNA Integrity Number 
(RIN)184 was measured. Samples with RIN < 7 and yield < 0.4 µg were excluded from further 
analyses, leaving 65 samples from patients with periodontitis and 64 from healthy controls.  
Thereafter, libraries were prepared with the Illumina stranded TruSeq protocol, which 
includes capture of polyA-RNA using polyT-coated magnetic beads, fragmentation of the 
RNA, reverse transcription, second strand synthesis with dUTP incorporation, sequencing 
adapter ligation, and amplification of adapter-ligated fragments by PCR, according to 
instructions provided by Illumina. Before proceeding to sequencing, a size selection step was 
performed to eliminate free adapters and primers.   
For Study III, DNA was extracted from all 96 saliva samples and a region of the 16S rRNA 
gene was amplified using PCR. After a clean-up step to remove free primers and potential 
primer-dimers, a second PCR step was performed in which the sequencing adapters were 
incorporated followed by one additional clean-up step, before proceeding to sequencing.  
Spatially resolved sequencing 
In Study IV, a new technique for spatially resolved RNA-seq was developed, and this method 
was also used for interrogation of gene expression within a periodontitis-affected gingival 
tissue section in Study V.  
In summary, this method utilizes a glass slide with primers printed onto it in an array-format. 
Each spot on the array contains primers with base pair sequences unique for each spot 
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(hereafter called barcodes), and polyT-sequences. A tissue section is placed onto the array 
and then stained with H&E and imaged under a microscope, in order to identify histological 
structures to be associated with the gene expression data. RNA is allowed to diffuse out of the 
tissue section and hybridize to the polyT-sequences of the primers on the array. Reverse 
transcription is thereafter performed in situ, resulting in barcoded cDNA attached to the glass 
surface. Thereafter, the tissue is removed from the glass slide and discarded while the 
barcoded cDNA is enzymatically cleaved off the glass slide and collected. To prepare 
libraries for sequencing, the collected cDNA is first subjected to second strand synthesis. 
Next, in vitro transcription is performed, which produces linearly amplified RNA fragments. 
The in vitro transcription is followed by ligation of sequencing adapters and another round of 
reverse transcription to produce cDNA. Finally, the fragments are amplified by PCR prior to 
sequencing. Each of the above-mentioned steps is followed by a clean-up step. 
 
ANALYSIS OF SEQUENCING DATA 
A sequencing run typically generates millions of raw data reads. The sequencing data are 
usually reported from the sequencer as FASTQ files, containing the actual sequences of bases 
read by the instrument, together with the quality of each base in the sequencing reads. These 
files need to be processed into interpretable information. The first step is to convert the 
sequences into gene or microbial counts. Thereafter, biological interpretations need to be 
made from the feature counts data, often by comparing two conditions, such as a pathological 
disease state against normal healthy.  
Quantification of transcripts or microbes 
All the presented studies in this thesis used paired end sequencing, which means that the 
sequencer reads each fragment from both ends and therefore reports two sequences for each 
fragment. In Study I, both reads in each read pair were aligned to a human reference genome. 
Duplication rates were calculated and samples having a high number of duplicated reads were 
deemed as having low quality and were excluded from further analysis, leaving 62 out of 65 
samples from patients with periodontitis and 62 out of 64 samples from healthy controls. 
Thereafter, the alignments were annotated to genes and quantified. Only pairs of reads where 
both reads were annotated to the same gene were included for analysis.  
In Study III, three samples which had less than 10,000 reads were excluded from further 
analysis, resulting in 46 samples from patients with periodontitis and 47 from healthy 
controls to be included in the analysis. The sequencing reads were processed with the 
Divisive Amplicon Denoising Algorithm 2 (DADA2) pipeline, which uses an error model, 
based on the quality scores provided by the sequencing platform, to correct reads.185 The 
corrected read pairs were merged and aligned to the Ribosomal Database Project (RDP) 
database and annotated at Phylum, Class, Order, Family, Genus and Species levels.  
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In Studies IV and V, from each generated pair of reads, one read contained the transcript and 
the other read contained the barcode. The reads containing the transcripts were aligned and 
annotated to a reference genome. The other read, containing the sequence from the barcode, 
was mapped against a reference file for translation into corresponding x and y coordinates on 
the array.  
Biological interpretation of transcripts/microbe abundances 
In Study I, exploratory data analysis was first performed using the multivariate statistical 
model Principal Component Analysis (PCA). Multivariate modelling is used to reduce 
dimensionality of complex data to render it easier to be explored and visualized. PCA is a 
commonly used dimensionality reduction method that transforms data into linear 
components, which can for example be visualized in a scatterplot.  
In addition to PCA, another dimensionality reduction technique, Orthogonal Partial Least 
Squares Discriminant Analysis (OPLS-DA; alternatively Orthogonal Projections to Latent 
Structures Discriminant Analysis) was used in Study I. OPLS-DA also calculates linear 
components, but also takes the outcome into consideration, which in this case is the disease 
status (periodontitis/healthy) and tries to find the variance within the dataset that best separate 
these two groups. Furthermore, variables with high reliability that influence the grouping 
separation (periodontitis/healthy) in the OPLS-DA can be identified, by constructing an 
S-plot.186 
Significant Analysis of Microarray Sequencing (SAMSeq), which uses both non-parametric 
testing and a resampling strategy to equalize library sizes, was employed to identify the 
dysregulated gene expression that differed between periodontitis and healthy groups.187 The 
reported up- and down-regulated genes were analysed for Gene Ontology (GO) categories in 
order to find functions that differed between periodontitis and health. Besides that, the lists of 
up- and down-regulated genes were also compared to differentially expressed genes 
downloaded from previous studies on systemic inflammatory conditions. A literature search 
for transcriptome analyses of diseases previously implied as associated with periodontitis was 
conducted. Available studies performed on biopsies from patients with disease and healthy 
controls, which reported up- and down-regulated genes, or raw data, were found for CVD, 
RA or UC. Differentially expressed genes were downloaded from these studies, or, in case of 
CVD, raw data was downloaded and processed as described by the authors of the study.188-192 
In Study III, the microbial data was first analysed by Principal Coordinate Analysis (PCoA), 
which is similar to PCA but is based on a distance matrix. In addition, sparse Partial Least 
Squares Discriminant Analysis (sPLS-DA) was used to identify differences between 
periodontitis and healthy based on both microbial data and levels of inflammatory mediators. 
This classification method is similar to OPLS-DA, however it contains a selection scheme 
where only a subset of the variables (microbiota and levels of inflammatory mediators) 
relevant for separating the classes is retained.193 
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For identifying microbiota that differed significantly between saliva samples from patients 
with periodontitis and healthy controls, DESeq2 was used, which includes median ratio 
normalization and negative binomial model of the count data that forms the basis of the 
statistical test.194 In addition, the machine learning method random forest was used as a 
second approach for identification of microbiota whose abundances differed between 
periodontitis and health.195 Random forest is a machine learning method used for 
classification of groups (in this case periodontitis and health), but it is also possible to extract 
variables important for the classification.195 In Study III this method was exploited for 
identifying microbiota specific for periodontitis and health.  
In Study V, the data was normalized by the median of ratios approach implemented in 
DESeq2. To visualize the high-dimensional data in a lower dimensional space, t-distributed 
Stochastic Neighbour Embedding (t-SNE) was used, which is a non-linear method that 
projects high-dimensional data in a two-dimensional scatter plot so that samples similar to 
one another clusters together and dissimilar points are placed more far apart from each 
other.196 
For investigating the localization of genes within subareas in the tissue section, the gene 
expression data was plotted in a scatter plot according to the x and y coordinates of each spot 
and with the spots coloured according to gene expression levels. This generated scatter plot 
was thereafter overlaid with the earlier captured image of the H&E stained tissue section. For 
identifying genes differentially expressed between different subareas, spots were selected 
based on where the spots were located, either within inflamed or non-inflamed regions. 
DESeq2 was used for identifying differentially expressed genes between these subareas. 
 
PROTEIN EXPRESSION ANALYSES 
For investigation of protein levels in gingival tissue as well as in saliva and GCF samples, the 
following techniques immunohistochemistry, enzyme-linked immunosorbent assay (ELISA) 
and Bio-plex multiplex immunoassay were employed in Studies I, II, and III. These 
techniques are similar in the aspect that they are based on antibody detection, but differ in the 
type of specimen they can analyse, as well as their throughput. Immunohistochemistry is 
employed for expression analysis of tissues and cells, whereas both ELISA and Bio-Plex are 
used for analysis of liquid samples.   
Immunohistochemistry 
Immunohistochemistry was employed to study the degree of inflammation within the 
gingival tissue, and the proteins expression levels corresponding to the genes identified by 
RNA-seq (Study I).  
To investigate B-cells and macrophages, tissues were stained with antibodies against cluster 
of differentiation 20 and 68 (CD20 and CD68), respectively. To confirm findings from the 
RNA-seq analysis, gingival tissues were stained with antibodies against MUC4, MMP7, and 
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PLEK. Immunohistochemical analyses were performed using primary monoclonal antibodies 
directed against CD20, CD68, MUC4, MMP7, or PLEK. After incubation with the primary 
antibodies, horseradish-peroxidase (HRP)-conjugated secondary anti-mouse antibodies were 
added to the slides, followed by addition of diaminobenzidine, which was oxidized by HRP 
to form a coloured product in the areas of the protein of interest. Finally, the slides were 
mounted and observed under a light microscope.  
The stainings were evaluated by three “blinded” observers. In case of MMP7, the extent of 
stained cells in the epithelium and connective tissue were assessed using a relative scale from 
0 to 3. The sections stained for MUC4, PLEK, CD20, or CD68 were examined for the 
presence or absence of stained cells in the epithelium and/or connective tissue.  
ELISA   
Pre-fabricated ELISA kits were employed to analyse the protein levels of MUC4 and MMP7 
in saliva and GCF samples in Study II. Briefly, the samples were added to wells pre-coated 
with capture antibodies directed against MUC4 or MMP7. Detection antibodies specific for 
MUC4 or MMP7 were added to the wells followed by addition of enzyme-linked secondary 
antibodies. Thereafter, a substrate was added, which was converted by the enzyme into a 
yellow coloured product. Finally, the absorbance was measured by a spectrophotometer to 
determine the concentration of MUC4 or MMP7 within the samples.  
Bio-Plex multiplex assay 
Bio-Plex was utilized in Study III to measure the levels of inflammatory mediators in saliva 
samples. Bio-Plex is similar to ELISA, however, with the capturing antibodies coated onto 
small beads (micrometer scale) instead of on the bottom of wells. In addition, the secondary 
antibodies are linked to biotin, which is detected by addition of streptavidin-coupled 
fluorophores, to increase the specificity and sensitivity of the assay.   
Multiple analytes can be investigated simultaneously in the same sample by including beads 
coated with antibodies against different analytes. To allow differentiation of beads, they are 
internally dyed with red and infrared fluorophores of different intensities where a specific 
known ratio of the two dyes are associated with a specific antibody. During analysis, the 
beads are read one by one and the combination of dyes (corresponding to a specific analyte) 
and fluorophore strength, reflecting the analyte’s concentrations, are detected and read.  
 
STATISTICAL ANALYSES 
In this section, statistical analyses other than those used for sequencing will be covered. This 
includes analysis from protein expression interrogations, RT-qPCR, and comparisons of 
patient characteristics.  
In Study I, the degree of inflammation was evaluated by three observers. For each sample, the 
median value for the three observers was calculated. The mean of the medians was obtained 
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from each group (periodontitis and healthy) and the difference between samples from patients 
with periodontitis and healthy controls was assessed using Mann-Whitney U-test. The 
amount of MMP7-positive cells in the epithelium and connective tissue was analysed 
similarly as described above. For MUC4, CD20, and CD68, the sections were examined for 
the presence of specific-stained cells. The values for the biopsies from periodontitis patients 
and healthy controls were compared using Fisher’s exact test.  
The results from the RT-qPCR analysis in Study I were calculated with the ∆∆Ct method197 
where the mean Ct for MUC4, MMP7, and PLEK were normalized against the mean Ct for 
GAPDH for each sample. All cell-based experiments were performed using cells from at least 
three individuals and each experiment was run with three technical replicates. The 
significances of the differences between cells stimulated with LPS and unstimulated control 
cells were assessed by Students t-test (two-tailed).  
In Study II, comparisons of patient characteristics were performed with Mann-Whitney U test 
for continuous variables. For dichotomous variables, cross tables were constructed and in 
case all cell values exceeded five, Chi-square χ2 test was used, otherwise Fisher’s exact test 
was used. Experimental results in Study II were evaluated by univariate analyses and 
regression models. The significance of difference of MUC4 and MMP7 levels between 
samples from patients with periodontitis and healthy controls were assessed by Mann-
Whitney U-test. Multiple regression analyses were performed with MUC4 or MMP7 levels as 
dependent variables, after log-transformation to achieve normality. Periodontitis status, age, 
and smoking habits were included as independent variables. In addition, logistic regression 
was performed with periodontitis as dependent variable and the ratio of MUC4/MMP7 
related to total protein concentrations, as well as age and smoking habits, was included as 
independent variables.  
In Study III, significance of differences between levels of inflammatory mediators in saliva 
samples from patients with periodontitis and healthy controls were assessed with Mann-
Whitney U-test. The p-values were adjusted with Benjamini-Hochberg post-hoc test.   
For all studies described above, p-values of less than 0.05 were considered statistically 
significant.  
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RESULTS AND DISCUSSION 
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he studies in this thesis focus on transcriptomic and taxonomic characterization of 
periodontitis. The transcriptome profiles of gingival tissue biopsies from patients 
with periodontitis were interrogated in Study I. In Study II, the proteins translated 
from the genes that were most highly associated with periodontitis, as identified in Study I, 
were analysed in saliva and GCF samples of periodontitis patients and healthy controls. 
Saliva samples were also investigated in Study III, with focuses on the microbiome of saliva 
in periodontitis and health. In Studies IV and V, the focus was again on transcriptome 
analysis, where, in Study IV, a technique for transcriptome analysis within tissue sections was 
developed, which was then applied to a gingival tissue biopsy from a patient with 
periodontitis in Study V. This section gives a brief overview of the results from these studies 
and a discussion of the findings related to current literature.  
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Degree of inflammation in gingival tissue biopsies from patients with 
periodontitis and healthy controls (Study I) 
In Study I, gingival biopsies were collected from patients with periodontitis and healthy 
controls. Each collected biopsy was divided in half where one half was subjected to 
RNA-seq, and the other half was fixed in buffered-formalin for histochemical analysis.  
Infiltration of inflammatory cells is one of the hallmarks of periodontal disease and therefore 
we initially investigated the extent of infiltration of inflammatory cells in gingival tissue of 
patients with periodontitis and healthy individuals. We assessed the degrees of inflammation 
of all biopsies by H&E staining as well as with cell-type-specific antibodies in 20 biopsies 
from periodontitis patients and 20 from healthy controls. Assessment of the H&E staining 
revealed significantly (p < 0.01) more infiltrating inflammatory cells in the periodontitis 
group. The biopsies from the patients with periodontitis also had significantly higher 
expressions of the B-cell marker CD20 and the macrophage marker CD68 (p < 0.01, and 
p = 0.02, respectively).  
Gene expression patterns related to periodontitis and health (Study I) 
The gene expression data was first investigated with multivariate methods in order to explore 
the overall patterns of gene expression of all samples, using PCA. In the PCA plot, the 
samples were labelled with colours either according to their degree of inflammation (as 
determined by histochemical analysis), or according to their disease status 
(periodontitis/healthy). This analysis revealed that the largest variation of gene expression 
within all samples was related to the degree of inflammation. The second largest variation 
was related to the disease status of the participant. The fact that the PCA identified gene 
expressions that differed between biopsies from patients with periodontitis and healthy 
individuals irrespective of the degree of inflammation, indicates that other mechanisms 
besides inflammation are involved in the transition from health to periodontitis.  
In addition to multivariate analysis, univariate differential expression analysis was performed 
on the gene expression data. Our statistical analysis revealed that 665 genes were 
up-regulated in periodontitis and 633 genes were down-regulated in periodontitis. The 
significantly up- and down-regulated genes were further analysed for enriched GO categories. 
The GO analysis demonstrated that the up-regulated genes were most strongly associated 
with functions relating to inflammation, defence, and wounding responses, as well as 
functions associated with apoptosis and cell death. On the other hand, down-regulated genes 
were related to organization of extracellular matrix, extracellular structure and collagen 
fibrils, development of skeletal system, bone, skin, ectoderm, and ectodermis, as well as 
ossification and osteoblast differentiation. Thus, the up-regulation of inflammatory processes 
in periodontitis is consistent with our initial findings that the degree of inflammation was 
higher in biopsies from periodontitis patients compared to healthy controls. In addition, the 
up-regulation of apoptotic processes and the down-regulation of processes related to 
structural support and development of skin and bone are consistent with clinical 
manifestations of periodontitis, which include loss of structural tissue and bone.  
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Subsequent analysis of the differentially expressed genes revealed MUC4 and MMP7 as the 
two most highly up-regulated genes in periodontitis. To our knowledge, neither MUC4 nor 
MMP7 has previously been reported as highly associated with periodontitis. The protein 
MUC4 is a member of the mucin family of glycoproteins, which up to date has 
20 members.148 Mucins are produced by mucus-producing epithelial cells after stimulation by 
microbial products and inflammatory mediators, including TNF-α and IL-1β, and by PMNs 
via neutrophil elastase.199-206 Although MUC4 has not previously been implicated in 
periodontitis, it has been reported as involved in cancer processes by mediating the epidermal 
growth factor family of enzymes, including the tyrosine kinase receptor ERBB2. This results 
in activation of downstream signal transduction pathways, including protein kinase C (PKC), 
which is involved in inflammation.207-209  
The enzyme MMP7 belongs to the MMP family of enzymes, which are the main proteins 
responsible for remodeling of the extracellular matrix; they are able to degrade basement 
membrane and extracellular matrix components, and contribute to the pathogenesis of 
periodontitis through destruction of periodontal tissue.124,210,211 In contrast to MMP7, other 
MMPs, mainly MMP2, 8, and 9, have previously been associated with periodontitis.124,212,213 
Notably, our study is the first to report an association between MMP7 and periodontitis, 
highlighting this MMP as potentially important for the pathogenesis of periodontitis.  
Expression of MUC4/MUC4 in gingival tissue, oral cells, saliva, and GCF 
(Studies I and II) 
Our finding that MUC4 was one of the two most highly up-regulated gene in periodontitis 
prompted us to further investigate the expression of the protein MUC4 in gingival tissue, the 
expression and regulation of MUC4 in oral cells, as well as the protein levels of MUC4 in 
saliva and GCF samples. First, the expression of MUC4 was verified at protein level in 
gingival tissue from patients with periodontitis and healthy controls. Immunohistochemical 
staining of 20 gingival biopsies from patients with periodontitis and 20 from healthy controls 
confirmed over-expression of the protein MUC4 in gingival tissue. MUC4 was detected in 
the gingival epithelium of 18 (90%) patients with periodontitis but only in 2 (10%) of healthy 
controls (p < 0.001).   
The regulation of MUC4 was thereafter investigated in vitro in oral cells. Due to the fact that 
the immunohistochemical analysis revealed MUC4 to be expressed only in the epithelium, 
the expression and regulation of MUC4 were analysed in epithelial cells. The cells were 
stimulated with LPS for 24 hours, which resulted in a significant (p < 0.01) increase of 
MUC4 expression, in comparison with cells treated with culture medium only.   
In Study II, the levels of MUC4 were further studied in saliva and GCF samples from patients 
with periodontitis and healthy individuals, with the purpose to explore the potential of MUC4 
as a diagnostic marker for periodontitis. The analysis revealed that the levels of MUC4 were 
significantly decreased both in saliva and GCF samples (p < 0.01 and p < 0.05, respectively) 
of patients with periodontitis compared to controls. The association between periodontitis and 
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levels of MUC4 remained significant (p < 0.05) even after adjusting for total protein 
concentrations, age, and smoking, both regarding saliva and GCF samples.  
The contrasting findings of MUC4 expression levels in gingival tissue compared to saliva and 
GCF may be due to the fact that MUC4 can be both in secreted and membrane-bound 
forms.199,214-216 The balance between these forms might be altered in response to 
inflammation.217 With regard to previous studies on mucins in saliva, it has previously been 
reported that levels of mucins are increased in saliva samples of periodontitis patients 
compared to healthy controls. However, these studies reported on mucins in general and did 
not distinguish between the different mucin family members.218-220 
Expression of MMP7/MMP7 in gingival tissue, oral cells, saliva, and GCF 
(Studies I and II) 
The second most highly up-regulated gene in gingival tissue from patients with periodontitis 
compared to healthy controls was MMP7. The expression of the protein product of the MMP7 
gene was also verified in gingival biopsies by immunohistochemical staining. Evaluation of 
the MMP7 protein expression in gingival tissue revealed a significantly (p < 0.01) elevated 
expression of MMP7 in connective tissue of gingival biopsies from periodontitis patients 
compared to controls (mean score 2.1 and 1.0, respectively). In contrast, there were no 
significant differences in expression of MMP7 in the epithelium of gingival tissues 
(p = 0.40). Our results that showed that MMP7 is overexpressed in connective tissue of 
gingival tissue of patients with periodontitis, but not in the epithelium, supports the 
suggestion that MMP7 is continuously expressed in epithelial cells to provide protection 
against microorganisms.221 
The regulation of MMP7 was also studied in in vitro experiments. Based on our findings that 
MMP7 was differentially expressed in the connective tissue and not in the epithelium, we 
used gingival fibroblasts, which are the most ubiquitous cells of the gingival connective 
tissue, for these experiments. Treatment of these cells with LPS for 24 hours significantly 
(p < 0.001) increased the gene expression of MMP7 in gingival fibroblasts.   
In addition, the protein expression of MMP7 was also determined in saliva and GCF samples 
from periodontitis patients and healthy controls (Study II). The MMP7 levels were 
significantly elevated in saliva and GCF samples (p < 0.05 and p < 0.01, respectively) of 
periodontitis patients compared to healthy individuals. However, the levels of MMP7 were 
not significantly increased in periodontitis after adjusting for total protein concentrations, age, 
and smoking. Levels of MMP7 have, to our knowledge, not previously been reported as an 
enriched marker in saliva samples from periodontitis patients as compared to healthy 
controls. Other members of the MMP family has however previously been reported as 
up-regulated in saliva during periodontitis, most notably MMP8.119,120,123,222 MMP7 can 
activate MMP8, thereby potentially promoting maintenance of periodontitis.223 
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Up-regulation of PLEK in periodontitis, CVD, RA, and UC (Study I) 
To identify common genes that might act as links between periodontitis and other chronic 
inflammatory diseases, we compared the genes differentially expressed in periodontitis 
(obtained from Study I) with genes up- and down-regulated in CVD, RA, and UC (obtained 
from previous studies). Our analysis revealed that similar processes, related to immune 
responses, cell motion, cell death, and homeostasis were up-regulated in all four diseases. The 
comparison revealed only one gene commonly up-regulated in all four diseases – PLEK. To 
further investigate our novel finding that PLEK was commonly up-regulated among the 
diseases investigated here, PLEK mRNA expression and regulation was analysed in oral cells 
and the protein expression was analysed in gingival tissue.   
Expression and regulation of PLEK was studied in vitro using gingival fibroblasts and 
epithelial cells. PLEK mRNA expression was significantly (p < 0.01) up-regulated in gingival 
fibroblasts in response to stimulation with LPS. In contrast, the mRNA expression of PLEK 
in epithelial cells was unaffected by LPS treatment. The protein expression of PLEK was also 
verified in biopsies of periodontitis patients and healthy individuals. PLEK was detected, by 
immunohistochemical staining, in association with fibroblast-like cells, epithelial cells, 
immune cells, and endothelial cells of gingival tissue from patients with periodontitis. In 
contrast, immunohistochemical analysis of gingival biopsies from healthy controls showed 
low proportion of stained cells.   
PLEK is an inducible PKC substrate expressed by macrophages implied to play an important 
role in the secretion and activation pathways of the pro-inflammatory cytokines TNF-α and 
IL-1β.224,225 In addition, it has been reported that PLEK is up-regulated in macrophages after 
stimulation with LPS, which is in line with our findings that PLEK is up-regulated in gingival 
fibroblasts after stimulation with LPS.226  
The reason for identification of only one common gene may depend on the fact that we 
compared data from our RNA-seq study with data obtained using microarrays. RNA-seq has 
been shown to outperform microarray technology, mainly due to higher precision in detecting 
transcript levels, which allows for better identification of differentially expressed genes.141,144-
147 However, additional studies are required to explore the involvement of PLEK in 
inflammatory diseases.   
Salivary microbial signatures in periodontitis (Study III) 
Periodontitis is induced by accumulation of microbes residing close to the gingiva, which 
triggers a host-immune response. The main objective of Study III was therefore to 
characterize the taxonomic composition of saliva samples from patients with periodontitis 
and healthy controls, by sequencing of the 16S rRNA gene. First, multivariate analysis was 
performed, which identified patterns of microbial compositions that differed significantly 
(p < 0.001) between saliva samples from patients with periodontitis and healthy individuals. 
The most abundant phyla across all samples were Firmicutes, Bacteroidetes, and 
Proteobacteria. However, Actinobacteria, Spirochaetes, Synergistetes, Tenericutes, candidate 
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division SR1 and Candidatus Saccharibacteria were significantly (adjusted p < 0.05) 
differentially abundant between periodontitis and health. Actinobacteria, Spirochaetes, 
Synergistetes, and Tenericutes were increased in saliva samples from patients with 
periodontitis, whereas candidate division SR1 and Candidatus Saccharibacteria were 
enriched in samples from healthy controls.  
In comparison with studies performed on plaque samples, our results from saliva samples are 
largely consistent with previous findings. Our findings that the phyla Spirochaetes, 
Synergistetes, and Tenericutes were increased in samples from patients with periodontitis are 
in agreement with previously published results.175,176,178,179 SR1, which we identified as more 
abundant in saliva samples from healthy controls, has previously been reported at low levels 
in saliva from healthy individuals, but it has not been reported as enriched in health compared 
to periodontitis.23 Nonetheless, our findings regarding Candidatus Saccharibacteria and 
Actinobacteria are in contrast to other published results.179,227 This discrepancy can be 
explained by differences in bacterial composition between plaque and saliva samples or 
technical variations between studies. For example, the results reported by Liu et al. (2012) 
identifying higher abundance of Candidatus Saccharibacteria in periodontitis included only a 
few plaque samples, from two patients with periodontitis and three healthy controls, and may 
not be generalizable for a larger study population.227 
At microbial level, bacterial species that had increased abundance in saliva samples from 
periodontitis patients compared to healthy controls included Prevotella sp., Phocaeicola sp., 
Fretibacterium sp., Streptococcus mitis/parasanguinis, Eubacterium saphenum, T. forsythia, 
F. alocis, and P. micra. Among these, four microbes could be assigned at species level, i.e. 
E. saphenum, T. forsythia, F. alocis, and P. micra; microbes that all have previously been 
associated with periodontitis in plaque samples.176,228-233 Moreover, F. alocis has also been 
reported as increased in saliva samples from patients with periodontitis compared to healthy 
controls.181 Interestingly, this microbe has also been proposed as the centre of a group of 
pathogens that are associated with periodontitis.229 Regarding the microbe that was assigned 
to both S. mitis and S. parasanguinis (meaning that these bacteria share the same sequence for 
the 16S rRNA gene region), has in case of S. mitis previously been reported as one of the 
early colonizers of the periodontal biofilm, whereas S. parasanguinis has been associated 
with aggressive periodontitis.28,234 The microbes that could not be assigned to specific species 
included microbes of the genera Prevotella, Phocaeicola, and Fretibacterium. Species 
belonging to the Prevotella genus, and most frequently P. intermedia, have previously been 
reported as associated with periodontitis.235,236 Interestingly, Fretibacterium species are 
gaining attention for their association with periodontitis. 225,229 It is also worth to mention that 
Phocaeicola species has previously been reported as more abundant in periodontitis by one 
study.233,237,238 
Salivary levels of inflammatory mediators (Study III) 
In addition to studying the salivary microbial composition, in Study III, the levels of 37 
different inflammatory mediators were analysed in the same saliva samples by Bio-Plex 
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immunoassay technology. The analysis revealed that glycoprotein 130 (gp130), soluble 
TNF-receptor 1 (sTNF-R1), and IL-19 were significantly (p < 0.05) enriched in saliva 
samples from periodontitis patients compared to controls. In contrast, the anti-inflammatory 
cytokine IL-10 was significantly (p < 0.05) increased in samples from healthy individuals. 
However, after adjusting for multiple testing, only the levels of gp130 remained significantly 
(adjusted p < 0.05) different when comparing the periodontitis patients with controls.  
The gp130 co-receptor subunit (also known as soluble IL-6 receptor β [sIL-6Rβ]) is required 
for signalling of a group of cytokines, namely IL-6, IL-11, IL-27, leukemia inhibitory factor 
(LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CT-1), 
cardiotrophin-like cytokine (CLC), and neuropoietin (NP). These cytokines are involved in a 
range of biological processes, including immune response, inflammation and bone 
homeostasis.239,240 Gp130 has not previously been reported as up-regulated in periodontitis. 
However, cytokines that signal through the gp130 subunit, namely IL-6 and OSM, have been 
reported as involved in periodontitis.240-246  
Associations between microbiota and inflammatory mediators in saliva 
samples (Study III) 
To investigate possible interactions between microbiota and host inflammatory response, the 
levels of inflammatory mediators were analysed in the same saliva samples as for the 
microbial composition analysis. The results showed that the inflammatory mediators gp130, 
sTNF-R1, sIL-6Rα, pentraxin 3, sTNF-R2, and chitinase 3-like 1 correlated positively with 
the microbes Streptococcus sp., Selenomonas sp., Treponema spp., Selenomonas sputigena 
and an unclassified Bacteria. The anti-inflammatory cytokine IL-10 was identified as 
negatively correlated to microbes assigned to S. mitis/parasanguinis, Eubacterium nodatum, 
and F. alocis, as well as to two microbes assigned to the order Clostridiales. In addition, IL-
10 also correlated positively with Granulicatella elegans, a bacterium found in normal 
human flora.247 These correlations may play important roles for the development and 
maintenance of the chronic inflammatory disease periodontitis.  
Candidate biomarkers for periodontitis (Studies II and III) 
In Study II, MUC4 and MMP7 were investigated as potential biomarkers for periodontitis 
using saliva and GCF samples. The results demonstrated that levels of both MUC4 and 
MMP7 could discriminate saliva and GCF samples of patients with periodontitis from 
samples of healthy controls. Interestingly, when MUC4 and MMP7 were analysed in 
combination, they had higher precision in discriminating periodontitis from health.  
In Study III, the microbial signatures of saliva samples from patients with periodontitis and 
healthy controls were interrogated. Several microorganisms were identified as more abundant 
in saliva samples from patients with periodontitis as compared to healthy individuals. The 
microorganisms identified at species level might have the possibility to serve as biomarkers 
due to the fact that these bacteria can potentially be cultured and be utilized as antigens for 
diagnostic antibody production. Therefore, we propose that the bacteria that were identified at 
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species level, that is E. saphenum, T. forsythia, F. alocis, and P. micra, might be used as 
biomarkers for early detection of periodontitis.  
Currently, only one biomarker, MMP8, is commercially available, in some European 
countries.5,139 The enzyme MMP8 has also repeatedly been reported as elevated in 
periodontitis.119,120,123,248 We propose that MMP8 together with the potential biomarkers we 
identified in Studies II and III, namely, MUC4, MMP7, gp130 and the microbial species 
E. saphenum, T. forsythia, F. alocis, and P. micra might have the possibility to form a panel 
of biomarkers for early prediction of periodontitis. However, to define a panel of biomarkers 
for prediction of periodontitis, prospective studies involving large cohorts should be 
performed.   
Spatially resolved transcriptome analysis – method development and analysis 
of gingival tissue (Studies IV and V) 
RNA-seq is commonly performed on homogenized whole biopsies. Gene expression data 
obtained from such analyses thus represent averages of the gene expression across all cells 
within the biopsies, and the information of the transcripts original localizations in the tissue 
are lost. Therefore, in Study IV, a novel strategy for spatially resolved analysis in tissue 
sections was developed and proof-of-concept experiments were performed on mouse 
olfactory bulb tissue. A series of analyses were carried out to evaluate the performance of this 
novel technique. Comparison of the total gene expression from a spatial transcriptomics 
experiment and corresponding experiment performed in solution revealed high correlation 
(r = 0.94), indicating that the spatial transcriptomics method does not introduce bias 
compared to protocols performed in solution. The results from spatial transcriptomics 
experiments were deemed reproducible because experiments performed on tissue replicates 
were highly correlated (r = 0.97 between adjacent tissue sections). Gene expressions in 
histologically similar areas were also compared, revealing high correlation (r = 0.93). In 
contrast, areas of histologically dissimilar domains of the tissue section were less correlated (r 
= 0.82) and genes differentially expressed between these domains could be identified. To 
investigate gene expression patterns within tissue sections, the multivariate analysis method t-
SNE was performed on the gene expression data. The analysis revealed distinct gene 
expression signatures that could be attributed to histologically dissimilar areas within the 
tissue section. These analyses demonstrate that the spatial transcriptomics method can be 
used for simultaneous analysis of gene expression in multiple domains within a tissue section, 
while also enabling the visualization of gene expression distribution within the section.  
In Study V, the spatial transcriptomics method was applied to periodontitis-affected gingival 
tissue to explore gene expression signatures of different cells present within gingival tissue 
during periodontitis. First, an overview of the gene expression data was obtained by t-SNE 
analysis. The t-SNE plot revealed that the gene expression within the tissue section could be 
clustered into three distinct groups. These groups were identified as corresponding to three 
histologically different areas within the tissue section; the epithelium, an inflamed region of 
the connective tissue, and non-inflamed connective tissue. In order to investigate gene 
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expression patterns differing between inflamed and non-inflamed regions within the tissue 
section, ten spots corresponding to inflamed connective tissue and ten spots corresponding to 
non-inflamed connective tissue were analysed. Differential expression analysis between these 
two areas was performed, which revealed 442 genes up-regulated in the inflamed area 
compared to the non-inflamed area. In contrast, no genes were identified as down-regulated 
in the inflamed area of the tissue, compared to the non-inflamed.  
The three most highly up-regulated genes in the inflamed areas were immunoglobulin lambda 
like polypeptide 5 (IGLL5), signal sequence receptor subunit 4 (SSR4), and marginal zone B 
and B1 cell specific protein (MZB1). The genes IGLL5 and MZB1 have previously been 
reported as up-regulated in gingival tissue biopsies from patients with aggressive or chronic 
periodontitis, compared to healthy controls.172,249 However, these two genes were identified 
from cohorts of 48 and 241 biopsies.172,249 By spatial transcriptomics, these genes could be 
identified as up-regulated using only one section of a biopsy. 
However, little is known about the function of the IGLL5 gene, but it is homologous to 
IGLL1, which is involved in B-cell development.250 The MZB1 protein regulates surface 
presentation and secretion of IgMs.251-253 The second most highly up-regulated gene, SSR4, 
encodes the delta subunit of the translocon-associated protein subunit (TRAP), which is 
involved in translocating proteins across the endoplasmic reticulum (ER) membrane.254-256 
There are indications that SSR4 is involved in beta cell survival in type 2 diabetes, but this 
gene has however, to our knowledge, not previously been reported as up-regulated in 
periodontitis-affected gingival tissue.257  
In the next series of analyses, the GO categories associated with the genes up-regulated in the 
inflamed area were investigated. The most enriched GO terms associated with the genes up-
regulated in the inflamed area of the tissue were related to functions associated with 
localization and targeting to the structure ER, which is responsible for the folding, processing, 
and trafficking of secreted and membrane-bound proteins, including many key components 
of the immune response.258 
To conclude, the spatial transcriptomics method can provide new insights into gene 
expression of clinical samples. Here, we have applied this method to a small gingival biopsy 
section from a patient with periodontitis. Using this technique, combining histological 
analysis and RNA-seq, we could detect both genes not previously implicated in periodontitis, 
and genes previously reported could be confirmed in this study.  
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STRENGTHS AND LIMITATIONS (STUDIES I-V) 
Study I  
This study is, to the best of our knowledge, the study that has investigated the largest number 
of gingival biopsies from patients with periodontitis in comparison to healthy controls, using 
RNA-seq. Large sample sizes lead to increased statistical power to detect differentially 
expressed genes.259  
The higher degree of inflammation within the biopsies from patients with periodontitis 
compared to controls could be interpreted either as a strength or a limitation. Infiltration of 
inflammatory cells is one of the hallmarks of periodontitis, and our finding that the levels of 
inflammatory cells were higher in tissue of periodontitis patients confirms that these patients 
have an active periodontal disease. On the other hand, the inflammation will result in higher 
expression of genes involved in inflammation that might be up-regulated also in a transient 
gingival inflammation, and which are thus not specific for periodontitis.  
One limitation of Study I is the validation of two up-regulated genes only. The transcriptome 
and proteome do not always correlate and, because the biological functions of interest are at 
protein level rather than at mRNA level, it is important to validate gene expression findings at 
the protein level.260 Due to lack of time and resources, this was not possible to perform in 
Study I. Nonetheless, the remaining up-regulated genes, as well as the genes down-regulated 
in periodontitis, deserve deeper investigation for evaluation of their roles in periodontal 
disease.  
Study II 
A limitation with Study II is the small sample size included in the study, and the results might 
therefore not be generalizable to a larger population. One advantage of this study is the 
validation of the findings in an additional cohort consisting of GCF samples from patients 
with periodontitis and healthy controls. However, the reproducibility of the findings 
regarding saliva needs to be investigated in larger cohorts of saliva samples.  
Study III 
Strengths with Study III include the relatively large number of saliva samples from patients 
with periodontitis and healthy controls, as well as the use of 16S rRNA gene sequencing. 
Study III is, to our knowledge, the study that has analysed the largest number of saliva 
samples from patients with periodontitis and healthy controls, using 16S rRNA gene 
sequencing. 16S rRNA gene sequencing can detect a wider range of taxa than hybridization 
based methods, which are restricted to sequences already printed onto the array. However, by 
sequencing only a region of the 16S rRNA gene, it is not possible to distinguish between 
closely related species, and some taxonomic classifications can only be made on genus level 
or higher.  
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Study IV 
Spatially resolved sequencing has several advantages both compared with traditional bulk 
measurements and single-cell RNA-seq approaches, as described in the introduction of this 
thesis. A strength with the spatial transcriptomics method developed in Study IV is that it is a 
transcriptome-wide approach and no prior knowledge of the sequences of the transcripts of 
interest is needed. Moreover, the technique can investigate several regions within a tissue 
section simultaneously, and there is no need for manual picking of the regions of interest. 
One weakness with this technique is the limited resolution. Resolution corresponding to 
dimensions of single cells would give more detailed information on gene expression of 
specific cells within tissue sections.  
Study V 
Previous studies on the transcriptome in periodontitis have been performed on whole gingival 
biopsies. Study V is the first study to investigate the transcriptome within a tissue section, thus 
associating tissue types within the tissue section to specific gene signatures. However, the 
investigation of sections from only one gingival biopsy limits the statistical power and the 
generalizability of the findings.  
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MAIN FINDINGS 
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STUDY I 
§ The largest variation of gene expression within the biopsies could be attributed to the 
degree of inflammation, and the second largest to the disease status of the individuals 
(periodontitis/healthy).  
§ The two genes most highly associated with periodontitis were MUC4 and MMP7. The 
protein products of MUC4 and MMP7 were also increased in gingival tissue biopsies 
from patients with periodontitis compared to controls.  
§ PLEK is commonly up-regulated in the chronic inflammatory diseases periodontitis, 
CVD, RA, and UC.  
 
STUDY II 
§ Protein levels of MUC4 and MMP7 in saliva and GCF samples differed significantly 
between patients with periodontitis and healthy individuals.  
 
STUDY III 
§ The microbial composition differed significantly between saliva samples from 
patients with periodontitis and healthy controls.  
§ Several microbes, including Prevotella sp., Phocaeicola sp., Fretibacterium sp., 
Streptococcus mitis/parasanguinis, Eubacterium saphenum, Tannerella forsythia, 
Filifactor alocis, and Parvinomas micra were more abundant in periodontitis, 
compared to healthy controls. 
§ The inflammatory mediator gp130 was more abundant in saliva samples from 
periodontitis patients compared to healthy individuals.  
 
STUDY IV 
§ The spatial transcriptomics method can be utilized to obtain spatially resolved gene 
expression profiles of tissue sections.  
 
STUDY V 
§ The different compartments within gingival tissue (epithelium, inflamed and non-
inflamed connective tissue) demonstrated distinct gene expression signatures.  
§ The genes IGLL5, SSR4, and MZB1 were the most highly up-regulated genes in 
inflamed connective tissue areas compared to non-inflamed.  
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n this thesis we report transcriptomic and taxonomic profiles of gingival tissue and saliva 
samples from patients with periodontitis and healthy individuals. Our characterization of 
periodontitis provides valuable insights into the pathogenesis of this common chronic 
inflammatory disease and suggests candidate biomarker proteins and microbes for future 
diagnostic assessment of periodontitis.  
We have used state-of-the-art sequencing technologies to profile the gene expression and 
microbiota in periodontitis. Study I used RNA-seq to characterize the transcriptome of 
gingival tissue of patients with periodontitis in comparison the healthy controls. Our results 
revealed MUC4 and MMP7 as the two most highly up-regulated genes in periodontitis. In a 
follow-up study, we found that the protein products of these two genes differed significantly 
between periodontitis and health, both in saliva and GCF samples, suggesting them as 
potential candidate biomarkers for periodontitis (Study II). Study III investigated microbial 
community compositions in saliva samples using 16S rRNA gene sequencing. The analysis 
identified several microorganisms that were enhanced in periodontitis, suggesting them as 
potential biomarkers for diagnostic assessment of periodontitis.  
To study gene expression with simultaneous localization of the transcripts within the tissue, a 
spatially resolved gene expression technique was devised in Study IV. This novel technique 
was applied to periodontitis-affected gingival tissue in Study V, which identified different 
gene signatures in the epithelium, inflamed connective tissue, and non-inflamed connective 
tissue, highlighting that gingival tissue is highly heterogeneous. Gene expressions in the 
inflamed and non-inflamed areas were compared, which identified 442 genes as up-regulated 
in the inflamed connective tissue. Among these, IGLL5, SSR4, and BMZ1 were the three most 
highly up-regulated genes.  
Study I of this thesis is to date the largest study to have interrogated the gene expression of 
periodontitis using RNA-seq. Moreover, spatially resolved gene expression profiling, as 
performed in Study V, has not previously been reported with regard to periodontitis. As 
sequencing technologies continue to improve in terms of throughput and costs, the number of 
studies on the transcriptome of periodontitis will probably increase. Since relatively few 
studies have been reported to date, this is welcome and could contribute to a more 
comprehensive picture of the genes that participate in this complex disease. However, to 
identify genes that are differentially expressed in periodontitis and health is only the first step 
of the process. The proteins are the molecules that are responsible for the functions within 
tissue, and with that in mind, the protein products of identified genes should be validated and 
further studied. Moreover, mechanistic and functional studies should be undertaken in order 
to gain further insight into the signalling mechanisms governing disease progression, which 
may lead to identification of therapeutic targets for the disease.  
The microbial community composition associated with periodontitis has been intensively 
studied, mainly in subgingival plaque samples. These studies have led to increased 
knowledge of the etiology of periodontitis, because of the spatial proximity of plaque to 
infected tissue. However, saliva is more suitable for diagnostic assessment of periodontitis 
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than plaque, because saliva is easier to sample and can give a description of all tooth sites in 
the mouth. Thus, our analysis of the microbial community patterns in saliva in periodontitis 
and health may provide microbial biomarkers for periodontitis.  
The field of periodontology has a rich history in biomarker research. However, to date, there 
are no commercial biomarkers available that can predict periodontitis with higher precision 
than clinical examinations. The expanding field of high-throughput sequencing has the 
potential to identify novel candidate biomarkers for periodontal disease. Future potential 
candidate biomarkers, as well as biomarkers that have been proposed to date, should be 
validated in large prospective studies. Due to the fact that periodontitis is a complex disease 
in which multiple factors contribute, a panel of markers will probably be more specific for 
diagnosis than single biomarkers. The candidate proteins and microbial biomarkers presented 
in this thesis may be included in such a panel.   
To sum up, the studies in this thesis have employed massively parallel sequencing to 
characterize the gene expression and microbiota associated with periodontitis in gingival 
tissue and saliva samples. The results from these studies add to current knowledge of genes 
involved in periodontitis, and identifies candidate biomarker proteins and microbes for future 
diagnostic assessment of this chronic inflammatory disease.  
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